We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,411

Holding the black bag: Personal health information and bankruptcy proceedings
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 10 2016

A recent decision of the Ontario Information and Privacy Commissioner (OPC) highlights the potentially broad application of the Personal Health


Update on Physician-Assisted Death: Superior Court Issues Practice Direction with Requirements for Bringing an Application
  • Borden Ladner Gervais LLP
  • Canada
  • February 4 2016

On January 15, 2016, the Supreme Court of Canada granted the Attorney General a further four month extension of the suspension of invalidity of the


Federal Court grants injunction that allows infringing biologic drug to stay on the market
  • Norton Rose Fulbright Canada LLP
  • Canada
  • June 20 2014

Case: AbbVie Corporation, AbbVie Deutschland GMBH & Co. KG and AbbVie Biotechnology Ltd. v. Janssen Inc., 2014 FC 489 Drug: Ustekinumab (STELARA®


Plaintiff’s right to videorecord independent medical examinations andor to have a nominee present
  • Field Law
  • Canada
  • February 21 2013

The plaintiff sued for personal injury as a result of a motor vehicle accident that occurred on 14 November, 2007. The plaintiff alleged injuries to


Sazant v. The College of Physicians and Surgeons of Ontario
  • Harper Grey LLP
  • Canada
  • March 17 2011

Dr. Sazant appealed from seven sets of Reasons issued by the College on procedural and substantive issues around findings that he committed professional misconduct with three boys, one of whom had been a patient, between 1970 and 1991


Federal Court of Appeal considers standard for “obvious to try” test
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • January 19 2016

On December 15, 2015, the Federal Court of Appeal confirmed that the correct standard for determining whether an invention is obvious under the


Court grants motion to reopen trial and admit new evidence
  • Borden Ladner Gervais LLP
  • Canada
  • April 27 2011

The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued


Applications for leave to appeal dismissed - 5 November 2015
  • Gowling Lafleur Henderson LLP
  • Canada
  • November 5 2015

The applicant had been issued a permit that allowed him to grow and use marijuana for personal, medicinal purposes. The grower permit regime was


Canadian patent law: 2015 year in review
  • Gowling Lafleur Henderson LLP
  • Canada
  • January 13 2016

A successful patentee in a patent infringement action is entitled to monetary compensation in relation to the acts of infringement. In this regard


Amgen’s cinacalcet application dismissed based on failure to meet selection patent criteria
  • Gowling Lafleur Henderson LLP
  • Canada
  • November 19 2015

Justice Phelan has dismissed an application by Amgen to prohibit the Minister of Health from issuing a Notice of Compliance to Mylan for Amgen’s